用于支持放射性药物治疗潜在肾毒性临床前评估的真实多区域小鼠肾脏剂量学模型
研究基于健康小鼠肾脏高分辨率MRI数据构建了计算多区域小鼠肾脏模型,用蒙特卡罗方法计算了5种肾脏组织对45种β或α发射放射性核素的S值。结果显示,考虑肾脏内非均匀活性分布后,131I标记单域抗体片段的亚器官组织剂量与假设全肾均匀分布的平均肾脏剂量偏差达-40%至57%,肾外纹吸收剂量约为皮质和内纹的2.0倍、内层组织的2.6倍。
要点
- 基于MRI数据构建了包含皮质、外髓外纹、外髓内纹、内髓及乳头肾盂5种组织的小鼠肾脏多区域模型。
- 肾脏内非均匀分布使131I标记抗体片段的亚器官剂量与假设均匀分布的平均肾脏剂量偏差-40%至57%。
- 肾外纹吸收剂量约为皮质和内纹的2.0倍、内层组织的2.6倍。
核心结论
- 使用肾脏区域S值可更真实地估计肾脏内摄取不均匀的治疗性放射性配体在不同肾组织中的吸收剂量。
- 这相比假设活性在整个肾脏组织中均匀分布的简化(较不准确)肾脏剂量估计是一种改进。
- 这种剂量学改进有望支持对更好理解人类肾毒性至关重要的临床前研究,该剂量学数据库对新分子载体的开发具有附加价值。
研究设计与样本
- 基于健康小鼠肾脏高分辨率MRI数据开发小鼠肾脏计算多区域模型。
- 使用蒙特卡罗计算为5种肾脏组织(皮质、外髓外纹、外髓内纹、内髓、乳头肾盂)计算45种β或α发射放射性核素的S值。
- 将区域S值应用于主要滞留于肾外髓外纹的131I标记单域抗体片段。
主要发现
- 所考虑的α发射体和低至中等能量β发射体在肾脏中的不均匀活性分布显著影响了特定亚器官区域的吸收剂量估计。
- 131I标记抗体片段非均匀分布产生的亚器官组织剂量与假设全肾均匀分布的平均肾脏剂量偏差为-40%至57%。
- 肾外纹吸收剂量约为皮质和外髓内纹的2.0倍,约为内层组织的2.6倍。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Suborgan absorbed dose estimates in mouse kidneys are crucial to support preclinical nephrotoxicity analyses of α- and β-particle-emitting radioligands exhibiting a heterogeneous activity distribution in the kidneys. This is, however, limited by the scarcity of reference dose factors (S values) available in the literature for specific mouse kidney tissues. Methods: A computational multiregion model of a mouse kidney based on high-resolution MRI data from a healthy mouse kidney was developed. The model was used to calculate S values for 5 kidney tissues (cortex, outer and inner stripes of outer medulla, inner medulla, and papilla and pelvis) for a wide range of β- or α-emitting radionuclides (45 in total) of interest for radiopharmaceutical therapy, using Monte Carlo calculations. Additionally, regional S values were applied for a 131I-labeled single-domain antibody fragment with predominant retention in the outer stripe of the renal outer medulla. Results: The heterogeneous activity distribution in kidneys of considered α- and low- to medium-energy β-emitters considerably affected the absorbed dose estimation in specific suborgan regions. The suborgan tissue doses resulting from the nonuniform distribution of the 131I-labeled antibody fragment largely deviated (from -40% to 57%) from the mean kidney dose resulting from an assumed uniform activity distribution throughout the whole kidney. The absorbed dose in the renal outer stripe was about 2.0 times higher than in the cortex and in the inner stripe and about 2.6 times higher than in inner tissues. Conclusion: The use of kidney regional S values allows a more realistic estimation of the absorbed dose in different renal tissues from therapeutic radioligands with a heterogeneous uptake in the kidneys. This constitutes an improvement from the simplistic (less accurate) renal dose estimates assuming a uniform distribution of activity throughout kidney tissues. Such improvement in dosimetry is expected to support preclinical studies essential for a better understanding of nephrotoxicity in humans. The dosimetric database has added value in the development of new molecular vectors for radiopharmaceutical therapy.
引用
- Vargas CS, Struelens L, D'Huyvetter M, et al. A Realistic Multiregion Mouse Kidney Dosimetry Model to Support the Preclinical Evaluation of Potential Nephrotoxicity of Radiopharmaceutical Therapy. J Nucl Med. 2022. PMID: 36229185. doi:10.2967/jnumed.122.264453
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。